Article

Clinical Trial and Ontology-Derived Positive and Negative Benchmark Datasets for Drug Repurposing Across Rare Diseases

2026-06-20

Abstract excerpt

Evaluating the potential applications of a medicine is a fundamental challenge in drug development. There is a lack of standardized, decision-oriented benchmarks that test whether computational models can generalize therapeutic hypotheses across diseases in ways that reflect real-world pharmaceutical investment decision making. To address this gap, we introduce two complementary resources: the Indication Expansion...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d4f9339a-5ab9-5e20-adfd-0b1be48be448
DOI: 10.64898/2026.06.15.732135

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Trial and Ontology-Derived Positive and Negative Benchmark Datasets for Drug Repurposing Across Rare DiseasesDOI 10.64898/2026.06.15.732135Read

CellAwareGNN: Single-Cell Enhanced Knowledge Graph Foundation Model for Drug Indication PredictionSemantic proximity Read

Systematic integration of biomedical knowledge prioritizes drugs for repurposingSemantic proximity Read

Representation Learning of Human Diseases for Indication Expansion and Investment DecisionsSemantic proximity Read

Drug repurposing for rare diseases via a gene-bridged heterogeneous knowledge graph and graph attention networkSemantic proximity Read

Building a knowledge graph to enable precision medicineSemantic proximity Read

An Integrated Knowledge Graph and Network Medicine Pipeline for Drug Repurposing: Benchmarking Across Human Diseases and Application to Amyotrophic Lateral SclerosisSemantic proximity Read

Disease networks and their contribution to disease understanding and drug repurposing: Evolution of the concept, techniques and data sourcesSemantic proximity Read

NetMedGPT - A network medicine foundation model for extensive disease mechanism mining and drug repurposingSemantic proximity Read

Integrating population-level and cell-based signatures for drug repositioningSemantic proximity Read

A Scalable Sign-Aware Multi-Omics Knowledge Graph Foundation Model for Mechanistic Drug Action and Clinical Response PredictionsSemantic proximity Read

SteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and AgingSemantic proximity Read

Graph Network-Based Analysis of Disease-Gene-Drug Associations: Zero-Shot Disease-Drug Prediction and Analysis StrategiesSemantic proximity Read